Perrigo | PRGO - Net Income


Perrigo reported $-398.6M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
AbbVie USD 695M 1.12B Mar/2026
Abbott USD 1.08B 699M Mar/2026
Bayer EUR 2.76B 6.52B Mar/2026
Bristol-Myers Squibb USD 2.68B 1.59B Mar/2026
Coherus Biosciences USD -37.64M 2.11M Dec/2025
Corcept Therapeutics USD -31.76M 56.05M Mar/2026
Dr.Reddys Laboratories INR 2.21B 9.89B Mar/2026
Eli Lilly USD 7.4B 760M Mar/2026
J&J USD 5.53B 299M Jun/2026
Merck USD -4.24B 7.2B Mar/2026
Nestle CHF 3.97B 1.1B Dec/2025
Pacira USD 2.92M 1.28M Mar/2026
Perrigo USD -398.6M 1.02B Mar/2026
Pfizer USD 2.69B 4.34B Mar/2026
Phibro Animal Health USD 27.46M 932K Dec/2025
Prestige Brands USD 46.7M 22.44M Dec/2025
Reckitt Benckiser GBP 284M 287M Dec/2024
Sanofi EUR 1.61B 2.42B Mar/2026
Supernus Pharmaceuticals USD -2.29M 1.81M Mar/2026
Teva Pharmaceutical Industries USD 369M 111M Mar/2026
Xeris Pharmaceuticals USD 2.23M 8.85M Mar/2026
Zoetis USD 601M 2M Mar/2026